Erste Asset Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Erste Asset Management’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-25,700	Closed	-$2.39M	–	576
2021 Q4	$2.39M	Hold	25,700	–	–	0.04%	281
2021 Q3	$1.54M	Hold	25,700	–	–	0.03%	295
2021 Q2	$1.8M	Hold	25,700	–	–	0.04%	293
2021 Q1	$1.73M	Hold	25,700	–	–	0.04%	288
2020 Q4	$1.97M	Sell	25,700 -5,000	-16%	-$375K	0.05%	267
2020 Q3	$2.32M	Buy	30,700 +4,200	+16%	+$280K	0.08%	228
2020 Q2	$1.66M	Hold	26,500	–	–	0.07%	250
2020 Q1	$1.12M	Hold	26,500	–	–	0.06%	240
2019 Q4	$1.22M	Hold	26,500	–	–	0.05%	261
2019 Q3	$1.21M	Hold	26,500	–	–	0.06%	241
2019 Q2	$1.53M	Buy	26,500 +10,000	+61%	+$517K	0.08%	209
2019 Q1	$732K	Buy	16,500 +3,200	+24%	+$147K	0.04%	272
2018 Q4	$512K	Buy	+13,300	New	+$522K	0.03%	307

Erste Asset Management's ARNA Position: Q1 2022 in Review

Erste Asset Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 25,700 shares — an estimated $2.39M sold.

Erste Asset Management first reported a position in ARNA in Q4 2018 and held it in 13 quarters. The position peaked at $2.39M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Erste Asset Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Erste Asset Management sold 25,700 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $2.39M.
Erste Asset Management first reported a position in Arena Pharmaceuticals Inc in Q4 2018 and held it in 13 quarters.
Erste Asset Management's Arena Pharmaceuticals Inc position peaked at $2.39M in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Erste Asset Management's 13F filing for Q1 2022, filed 25 Nov 2024.